Presentation Materials | Investor Relations | CHUGAI PHARMACEUTICAL CO., LTD.

Skip To Voice Support Menu
For Body
For Menu
For Local Menu

Home > Investor Relations > Reports & Downloads > Presentation Materials

Feb 02, 2012: Information Meeting on FY 2011.12 Financial Results

Aiming to Become a Top Japanese Pharmaceutical Company - 2011 Results & 2012 Outlook -: Osamu Nagayama, President and CEO
FY2011 Consolidated Financial Overview: Yoshio Itaya, Senior Vice President and CFO
Overview of Development Pipeline: Yutaka Tanaka, Senior Vice President,
Head of Lifecycle Management & Marketing Unit

Results for [All]

2011

Oct 28	Chugai-RDKK PHC Seminar Personalized Healthcare (PHC) Approach in Chugai [4.4MB] Webcasts
Oct 21	3Q Results (Jan 11 - Sep 11) Conference Call 3Q Results (Jan 11 - Sep 11) Conference Call [337KB] Webcasts
Jul 22	Information Meeting on FY 2011.12 2Q Financial Results Information Meeting on FY 2011.12 2Q Financial Results [487KB] Webcasts
Apr 21	1Q Results (Jan 11 - Mar 11) Conference Call 1Q Results (Jan 11 - Mar 11) Conference Call [261KB] Webcasts
Feb 03	Information Meeting on FY 2010.12 Financial Results Information Meeting on FY 2010.12 Financial Results [685KB] Webcasts

2010

Oct 22	3Q Results (Jan 10 - Sep 10) Conference Call 3Q Results (Jan 10 - Sep 10) Conference Call [401KB] Webcasts
Oct 08	Information Meeting Roche: adapting to the changing environment [758KB] Aiming to Become a Top Japanese Pharmaceutical Company ～Advancing into the Next Stage〜 [1.9MB] Webcasts
Sep 29	Deutsche Bank Conference Deutsche Bank Conference [282KB]
Sep 08	Information Meeting on Actemra Information Meeting on Actemra [1MB] Webcasts
Jul 23	Information Meeting on FY 2010.12 2Q Financial Results Information Meeting on FY 2010.12 2Q Financial Results [447KB] Webcasts
Apr 23	1Q Results (Jan 10 - Mar 10) Conference Call 1Q Results (Jan 10 - Mar 10) Conference Call [306KB] Webcasts
Feb 04	Information Meeting on FY 2009.12 Financial Results Webcasts Information Meeting on FY 2009.12 Financial Results [716KB]

2009

Dec 07	Information Meeting on Diabetes Products Information Meeting on Diabetes Products [1MB]
Dec 01	Nomura Investment Forum 2009 Nomura Investment Forum 2009 [377KB]
Oct 27	3Q Results (Jan 09 - Sep 09) Conference Call FY2009 3Q Consolidated Financial Overview Overview of Development Pipeline [328KB]
Sep 30	Deutsche Bank Conference Deutsche Bank Conference [387KB]
Aug 26	Tour of Utsunomiya Plant Observation on Follow-on Biologics / Biosimilars [1.2MB]
Jul 24	Information Meeting on FY 2009.12 2Q Financial Results FY2009 2Q Consolidated Financial Overview [213KB] Overview of Development Pipeline [186KB]
Apr 24	1Q Results (Jan 09 - Mar 09) Conference Call FY2009 1Q Consolidated Financial Overview Overview of R&D Activities　 [297KB]
Mar 27	Information Meeting Aiming to Become a Top Japanese Pharmaceutical Company with Global-Level Capabilities [1.7MB]
Feb 05	Information Meeting on FY 2008.12 Financial Results FY2008 Consolidated Financial Overview [194KB] Overview of Development Pipeline [137KB]

2008

Oct 21	3Q Results (Jan 08 - Sep 08) Conference Call FY2008 3Q Consolidated Financial Overview [176KB]
Sep 02	Media Conference on Avastin Overview of Avastin and Assessment of its Proper Use in Japan [705KB] Progress in the Treatment of Metastatic Colorectal Cancer [993KB]
Aug 01	Information Meeting on 2008.12 Half-Year Financial Results FY2008 Interim Consolidated Financial Overview [203KB] Overview of R&D Activities [117KB]
May 22	Information Meeting on Actemra Product Overview of Actemra [779KB] Treatment evolution - from "alleviating & delaying" to "stopping" disease progression - [598KB]
Apr 22	1Q Results (Jan 08 - Mar 08) Conference Call FY2008 1Q Consolidated Financial Overview Overview of R&D Activities [185KB]
Mar 03	Media Conference on Herceptin Herceptin [986KB] Adjuvant Therapy with Trastuzumab [1.6MB] Pharmacoeconomics of Trastuzumab (Herceptin) [445KB]
Jan 31	Information Meeting on FY 2007.12 Financial Results New Mid-Term Business Plan "Sunrise 2012" [213KB] FY2007 Consolidated Financial Overview [213KB] Overview of R&D Activities [117KB]

Earlier Presentation Materials

TSE Code:4519

(About 20 min delay)

Chart

To view PDF files,
you will need Adobe® Reader® which is available as a free download.